gamma-aminobutyric Acid (GABA) A Receptor, alpha 1 (GABRA1) Peptide
Quick Overview for gamma-aminobutyric Acid (GABA) A Receptor, alpha 1 (GABRA1) Peptide (ABIN8101259)
Target
Source
Application
-
-
Purpose
- GABRA1 Peptide
-
-
gamma-aminobutyric Acid (GABA) A Receptor, alpha 1 (GABRA1) peptide
GABRA1 Host: Synthetic BP, WB, IHC
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-GABRA1 antibody ( ARP34976_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- GABRA1 (gamma-aminobutyric Acid (GABA) A Receptor, alpha 1 (GABRA1))
-
Background
-
Targeted Subunit: alpha-1
Background Information: GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified.
Alternative Symbols: EJM, ECA4, EJM5
-
Molecular Weight
- 52kDa
-
Gene ID
- 2554
-
NCBI Accession
- NP_000797
-
UniProt
- P14867
Target
-
